Understanding brain tumour risk factors

Understanding the risk factors for brain cancer can help provide insight into how it develops. Each year, thousands of people are diagnosed with a primary brain tumour, and an exact cause isn’t always known. Typically, a diagnosis of brain cancer isn’t related to anything you have or haven’t done and only a small percentage—about 3%—of cases are preventable. There are over 100 different types of brain tumour and no single risk factor accounting for the majority of cases has been found. Risk factors can be either preventable or non-preventable.

Non-preventable risk factors

Some risk factors for brain tumours are beyond our control. These include demographic and genetic influences, such as age, gender, and family history, as well as certain medical conditions and treatments. Understanding these factors can help in early detection and management.

• Age – The risk of cancer is higher in older adults and this includes brain cancer, which is more common in those over 75 years old.

• Gender – Women in the UK are slightly more likely to be diagnosed with a brain tumour over their lifetime than men.

• Genetics – Certain genetic conditions can increase the risk of developing a brain tumour, these include – Neurofibromatosis (NF) type 1 and 2 and Tuberous Sclerosis (TSC), Von Hippel Lindau disease and Li Fraumeni syndrome.

• Family History – If an immediate family member such as a sibling or parent has had a brain or spinal cord tumour, your risk of developing one is up to two times higher than the general population. The risk varies between subtypes of brain tumour.

Preventable risk factors

While the majority of brain tumours aren’t preventable, there are some environmental and lifestyle factors that influence risk.

• Obesity – Around 2% of brain and CNS tumours are related to obesity. The risk of developing a meningioma is around 60% higher in women who are obese.

• High birth weight – A birth weight of over 4kg is associated with conditions like gestational diabetes and is linked to a higher risk of primary brain and CNS tumours in childhood.

• HIV/AIDS – People with these conditions have an increased risk of developing CNS lymphoma due to a weakened immune system. Antiretroviral therapy can slow or reverse the progression of HIV and preserve the immune system, reducing the risk of this complication.

• Occupational exposure – Exposure to certain chemicals at work may increase the risk of developing brain cancer. These include non-arsenical insecticides, epichlorohydrin, inorganic lead, and chemicals used in petroleum refining. Workers in agriculture, rubber industries, and chemical manufacturing might be at higher risk due to these substances.

Does Radiation Cause Brain Cancer?

Yes, some forms of radiation can cause brain tumours. Ionising radiation, used in some radiological examinations like X-rays and radiation therapy has been linked to brain tumours.

• X rays and CT scans:  Less than 1% of brain and other CNS tumour cases in the UK are caused by ionising radiation. This includes X-rays, CT scans, and radiotherapy, which can increase the risk of developing brain and CNS tumours. Research has found that childhood CT scans can triple the risk of benign brain tumours, leukaemia, and other brain tumours.

However, these cancers are rare, translating to approximately a 0.01% (one in 10,000) chance of developing leukaemia or a brain tumour in the 10 years following the first scan for patients under 10. While the clinical benefits of CT scans often outweigh these risks, minimizing radiation doses and considering alternative, non-ionising procedures when appropriate is crucial to reduce potential harm.

• Radiotherapy: This treatment for childhood cancers is linked to a higher risk of gliomas and meningiomas later in life. Higher doses of radiation therapy are associated with a greater risk of developing brain and nervous system tumours. Yet, radiotherapy is only given in specific situations, usually as a lifesaving treatment where the benefits outweigh the risks.

Do Mobile Phones Cause Brain Tumours?

Mobile phones use radiofrequency (RF) signals, a form of non-ionising radiation that isn’t strong enough to damage DNA like X-rays or gamma rays, making their link to cancer unclear. Research on whether mobile phones are linked to a higher risk of brain cancer is inconclusive, and no clear link has been established.

Interestingly, some research has suggested a possible connection between an increased risk of primary brain tumours and long-term mobile phone use, but limitations in many of them prevent firm conclusions. Notably, mobile phones have only been widely used for about 20 years, so the long-term effects are unknown, especially for children and teenagers, whose usage patterns differ from adults.

Ultimately, it’s not possible to rule out the effects of mobile phones on brain cancer risk and research. If you want to reduce your exposure to RF signals, you can:

• Use speakerphone or earphones to keep the antenna as far from your head as possible
• Limit the length of calls
• Set a time limit on your daily phone use
• Text instead of calling.

Are brain tumours hereditary?

In some very rare cases, brain tumours can run in families, but these are related to specific and rare genetic conditions and genetic mutations, such as POT1 and HERC2. We know that having a first-degree or direct relative with a brain or CNS tumour increases your risk of developing cancer, but this doesn’t mean that there is a certainty of developing one. Unlike traits like hair or eye colour, brain tumours are not inherited in a straightforward way. The presence of these genetic factors only raises the likelihood, without guaranteeing the occurrence of brain tumours.

Putting your mind at ease

Understanding the risk factors for brain cancer can provide a sense of clarity and control during a challenging time. While many of these factors are beyond our control, being informed can help with early detection and management. Remember, a diagnosis of brain cancer is rarely due to anything you have or haven’t done.

At Gena, we’re committed to supporting you through your journey with comprehensive tools and resources. Our platform streamlines clinical trial enrolment, provides a free management tool for your clinical correspondence, and delivers digestible insights from genomic sequencing. Sign up with Gena to take control of your health and access these resources.

References:

1. Cancer Research UK, https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/brain-other-cns-and-intracranial-tumours/risk-factors#heading-Zero, accessed June 2024
2. Nayak, L., & Iwamoto, F. M. (2010). Primary brain tumors in the elderly. Current neurology and neuroscience reports, 10(4), 252–258. https://doi.org/10.1007/s11910-010-0110-x
3. Hemminki, K., Tretli, S., Olsen, J. H., Tryggvadottir, L., Pukkala, E., Sundquist, J., & Granström, C. (2010). Familial risks in nervous system tumours: joint Nordic study. British journal of cancer, 102(12), 1786–1790. https://doi.org/10.1038/sj.bjc.6605708
4. Hemminki, K., Tretli, S., Sundquist, J., Johannesen, T. B., & Granström, C. (2009). Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. The Lancet. Oncology, 10(5), 481–488. https://doi.org/10.1016/S1470-2045(09)70076-2
5. Scheurer, M. E., Etzel, C. J., Liu, M., Barnholtz-Sloan, J., Wiklund, F., Tavelin, B., Wrensch, M. R., Melin, B. S., Bondy, M. L., & GLIOGENE Consortium (2010). Familial aggregation of glioma: a pooled analysis. American journal of epidemiology, 172(10), 1099–1107. https://doi.org/10.1093/aje/kwq261
6. Sergentanis, T. N., Tsivgoulis, G., Perlepe, C., Ntanasis-Stathopoulos, I., Tzanninis, I. G., Sergentanis, I. N., & Psaltopoulou, T. (2015). Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis. PloS one, 10(9), e0136974. https://doi.org/10.1371/journal.pone.0136974
7. Brown, K. F., Rumgay, H., Dunlop, C., Ryan, M., Quartly, F., Cox, A., Deas, A., Elliss-Brookes, L., Gavin, A., Hounsome, L., Huws, D., Ormiston-Smith, N., Shelton, J., White, C., & Parkin, D. M. (2018). The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. British journal of cancer, 118(8), 1130–1141. https://doi.org/10.1038/s41416-018-0029-6
8. Brown, T., Young, C., Rushton, L., & British Occupational Cancer Burden Study Group (2012). Occupational cancer in Britain. Remaining cancer sites: brain, bone, soft tissue sarcoma and thyroid. British journal of cancer, 107 Suppl 1(Suppl 1), S85–S91. https://doi.org/10.1038/bjc.2012.124
9. Huang, W. Y., Muo, C. H., Lin, C. Y., Jen, Y. M., Yang, M. H., Lin, J. C., Sung, F. C., & Kao, C. H. (2014). Paediatric head CT scan and subsequent risk of malignancy and benign brain tumour: a nation-wide population-based cohort study. British journal of cancer, 110(9), 2354–2360. https://doi.org/10.1038/bjc.2014.103
10. Pearce, M. S., Salotti, J. A., Little, M. P., McHugh, K., Lee, C., Kim, K. P., Howe, N. L., Ronckers, C. M., Rajaraman, P., Sir Craft, A. W., Parker, L., & Berrington de González, A. (2012). Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet (London, England), 380(9840), 499–505. https://doi.org/10.1016/S0140-6736(12)60815-0
11. Taylor, A. J., Little, M. P., Winter, D. L., Sugden, E., Ellison, D. W., Stiller, C. A., Stovall, M., Frobisher, C., Lancashire, E. R., Reulen, R. C., & Hawkins, M. M. (2010). Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28(36), 5287–5293. https://doi.org/10.1200/JCO.2009.27.0090
12. Prasad, M., Kathuria, P., Nair, P., Kumar, A., & Prasad, K. (2017). Mobile phone use and risk of brain tumours: a systematic review of association between study quality, source of funding, and research outcomes. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 38(5), 797–810. https://doi.org/10.1007/s10072-017-2850-8
13. Henry, M. L., Osborne, J., & Else, T. (2020). POT1 Tumor Predisposition. In M. P. Adam (Eds.) et. al., GeneReviews®. University of Washington, Seattle.
14. Choi, D. J., Armstrong, G., Lozzi, B., Vijayaraghavan, P., Plon, S. E., Wong, T. C., Boerwinkle, E., Muzny, D. M., Chen, H. C., Gibbs, R. A., Ostrom, Q. T., Melin, B., Deneen, B., Bondy, M. L., Gliogene Consortium, Genomics England Research Consortium, Bainbridge, M. N., Amos, C. I., Barnholtz-Sloan, J. S., Bernstein, J. L., … Zarowiecki, M. (2023). The genomic landscape of familial glioma. Science advances, 9(17), eade2675. https://doi.org/10.1126/sciadv.ade2675